Qure.ai Adds Lung Health Expert to Boost Clinical Strategy
Dr. Javier J. Zulueta enters boardroom as Chief Medical Officer, Pulmonology, with potential of adjusting the lung most cancers survival curve in a single era
Qure.ai has appointed Dr. Javier J. Zulueta, beforehand Professor of Drugs on the Icahn Faculty of Drugs at Mount Sinai in New York and Pulmonary Division Chief at Mount Sinai Morningside Hospital, to a brand new place of Chief Medical Officer, Pulmonology.
The function will dovetail his deep scientific perception to the continued analysis & improvement in lung well being AI and digital well being care coordination options to bolster Qure.ai’s tempo of enterprise growth within the USA and Europe.
Prashant Warier, Founder and CEO of Qure.ai states, “We warmly welcome Dr. J, Zulueta to carry his unmatched world experience in lung most cancers screening and administration to Qure.ai. His data might be instrumental within the ongoing strategic improvement of our Lung Most cancers Suite of AI-powered options and to drive scientific deployments in well being techniques and hospitals at scale.”
Dr. Javier J. Zulueta, Chief Medical Officer at Qure.ai states, “Lung most cancers stays the deadliest most cancers on this planet, not as a result of we will’t deal with it, however as a result of we discover it too late. We stand at a pivotal second in scientific and expertise disruption the place the facility of AI may be harnessed safely to show small incidental lung nodule findings into lifesaving interventions. Becoming a member of Qure.ai places me on the epicentre of this modification – we’ve got the potential to vary the survival curve in a single era.”
Dr. Zulueta brings greater than three a long time of expertise as a doctor, scientist, academician and pioneer in interventional pulmonology, lung most cancers screening and pulmonary nodule/illness administration. Previous to Mount Sinai, he based and led the inaugural Division of Respiratory Drugs at Clinica Universidad de Navarra in Pamplona, Spain’s premier medical faculty, the place he launched the nation’s first lung most cancers screening program as Principal Investigator of the Worldwide Early Lung Most cancers Motion Program (IELCAP). His ardour within the development of early lung most cancers detection by way of medical expertise has additionally led to him taking a variety of previous roles with business corporations as an Advisory Board Member.
The brand new CMO appointment builds on a fast tempo of enterprise scaling for Qure.ai within the USA. In the beginning of 2025 it appointed Jim Mercadante as Chief Business Officer, adopted by a dozen enterprise improvement, gross sales and strategic account administration appointments throughout the States. Just lately, Qure.ai was additionally acknowledged as a TIME100 Most Influential Firm 2025 for using AI to reshape entry and analysis of high-burden illnesses worldwide. Qure.ai is deployed in additional than 100 nations and has 18 FDA cleared findings.
The submit Qure.ai Adds Lung Health Expert to Boost Clinical Strategy first appeared on AI-Tech Park.
